{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:35:21Z","timestamp":1794652521232,"version":"4.9.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.eururo.2023.02.027","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T20:17:44Z","timestamp":1678393064000},"page":"548-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update"],"prefix":"10.1016","volume":"83","author":[{"given":"Oscar R.","family":"Brouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Protzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Antunes-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fern\u00e1ndez-Pello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel S.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.S.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Kailavasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Manzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack David","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herney A.","family":"Garcia-Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bryan","family":"Rumble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios I.","family":"Sakalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Zapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"S\u00e1nchez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.02.027_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euros.2022.04.002","article-title":"What is the most effective management of the primary tumor in men with invasive penile cancer: a systematic review of the available treatment options and their outcomes","volume":"40","author":"Sakalis","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2023.02.027_b0010","unstructured":"Sakalis V, Tagawa S, Brouwer O, et al. Management of lymph node-positive penile cancer: a systematic review. PROSPERO. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=290784."},{"key":"10.1016\/j.eururo.2023.02.027_b0015","unstructured":"Fernandez-Pello S, Sakalis V, Greco I, et al. Nodal staging in penile cancer: a systematic review and meta-analysis. PROSPERO. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=395174."},{"key":"10.1016\/j.eururo.2023.02.027_b0020","doi-asserted-by":"crossref","first-page":"e34874","DOI":"10.2196\/34874","article-title":"Global pattern and trends in penile cancer incidence: population-based study","volume":"8","author":"Fu","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.eururo.2023.02.027_b0025","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","article-title":"Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956\u20132015","volume":"142","author":"Hansen","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.21037\/atm-20-1802","article-title":"Incidence trends and survival outcomes of penile squamous cell carcinoma: evidence from the Surveillance, Epidemiology and End Results population-based data","volume":"8","author":"Qi","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.eururo.2023.02.027_b0035","unstructured":"Cancer Research UK. Penile cancer incidence trends over time. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/penile-cancer\/incidence#heading-Two."},{"key":"10.1016\/j.eururo.2023.02.027_b0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0050","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ijc.21961","article-title":"Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival","volume":"119","author":"Lont","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0055","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO;2-C","article-title":"Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"91","author":"Bezerra","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/tau.2017.05.19","article-title":"Updates on the epidemiology and risk factors for penile cancer","volume":"6","author":"Douglawi","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0065","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. WHO classification of tumours, volume 8. ed. 5. Lyon, France: IARC; 2022."},{"key":"10.1016\/j.eururo.2023.02.027_b0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.semdp.2014.12.017","article-title":"Pathological factors, behavior, and histological prognostic risk groups in subtypes of penile squamous cell carcinomas (SCC)","volume":"32","author":"Sanchez","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.eururo.2023.02.027_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.eururo.2023.02.027_b0080","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-5347(17)35221-7","article-title":"Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system","volume":"151","author":"Horenblas","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0085","article-title":"Trends in incidence, mortality, and survival of penile cancer in the United States: a population-based study","volume":"12","author":"Deng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0090","series-title":"Carcinoma of the penis and distal urethra histopathology reporting guide","author":"Corbishley","year":"2017"},{"key":"10.1016\/j.eururo.2023.02.027_b0095","series-title":"TNM classification of malignant tumours","author":"Brierley","year":"2016"},{"key":"10.1016\/j.eururo.2023.02.027_b0100","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2023.02.027_b0105","first-page":"S2","article-title":"Patient presentation, differential diagnosis, and management of penile lesions","volume":"13","author":"Chipollini","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2023.02.027_b0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00261-004-0201-8","article-title":"Primary and secondary malignancies of the penis: ultrasound features","volume":"30","author":"Bertolotto","year":"2005","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.eururo.2023.02.027_b0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.eururo.2006.11.014","article-title":"The role of magnetic resonance imaging in the local staging of penile cancer","volume":"51","author":"Kayes","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urology.2016.01.003","article-title":"Role of penile Doppler US in the preoperative assessment of penile squamous cell carcinoma patients: results from a large prospective multicenter European study","volume":"90","author":"Bozzini","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0125","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MOU.0b013e3282f151fd","article-title":"Functional imaging in penile cancer: PET\/computed tomography, MRI, and sentinel lymph node biopsy","volume":"18","author":"Mueller-Lisse","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0135","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1464-410X.2009.08450.x","article-title":"Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in staging clinically node-negative patients with penile carcinoma","volume":"104","author":"Leijte","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.urolonc.2009.10.012","article-title":"Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET\/CT: a prospective single-center study","volume":"30","author":"Schlenker","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0145","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00432-022-04012-2","article-title":"Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer","volume":"148","author":"Fankhauser","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0150","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015","article-title":"Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients","volume":"58","author":"Graafland","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.ju.0000132239.28989.e1","article-title":"Long-term followup of penile carcinoma treated with penectomy and bilateral modified inguinal lymphadenectomy","volume":"172","author":"d\u2019Ancona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11701-020-01189-x","article-title":"Comparative study of perioperative and survival outcomes after video endoscopic inguinal lymphadenectomy (VEIL) and open inguinal lymph node dissection (O-ILND) in the management of inguinal lymph nodes in carcinoma of the penis","volume":"15","author":"Thyavihally","year":"2021","journal-title":"J Robot Surg"},{"key":"10.1016\/j.eururo.2023.02.027_b0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bju.15700","article-title":"High diagnostic accuracy of inguinal ultrasonography and fine-needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes","volume":"130","author":"Lee","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bju.15725","article-title":"Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer","volume":"130","author":"Wever","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2020.09.007","article-title":"Hybrid indocyanine green-(99m)Tc-nanocolloid for single-photon emission computed tomography and combined radio- and fluorescence-guided sentinel node biopsy in penile cancer: results of 740 inguinal basins assessed at a single institution","volume":"78","author":"Dell\u2019Oglio","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0180","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s11255-016-1405-x","article-title":"Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis","volume":"48","author":"Zou","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2023.02.027_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bju.15678","article-title":"Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation","volume":"130","author":"de Vries","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00345-008-0288-6","article-title":"Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer","volume":"27","author":"Hughes","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.eururo.2023.02.027_b0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.eururo.2009.05.016","article-title":"Scanning with 18F-FDG-PET\/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma","volume":"56","author":"Graafland","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0205","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41443-020-0327-4","article-title":"Human papilloma virus (HPV) status may impact treatment outcomes in patients with pre-cancerous penile lesions (an eUROGEN Study)","volume":"33","author":"Ashley","year":"2021","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2023.02.027_b0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/iju.13871","article-title":"Penile intraepithelial neoplasia: Nomenclature, incidence and progression to malignancy in the Netherlands","volume":"26","author":"Hoekstra","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0215","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/09546634.2020.1800574","article-title":"The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature","volume":"33","author":"Kravvas","year":"2022","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.eururo.2023.02.027_b0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2010.09.039","article-title":"Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes","volume":"59","author":"Shabbir","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0090-4295(98)00088-0","article-title":"Buccal mucosal grafts for urethral reconstruction","volume":"51","author":"Caldamone","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/21681805.2014.955822","article-title":"Organ-sparing reconstructive surgery in penile cancer: initial experiences at two Swedish referral centres","volume":"49","author":"H\u00e5kansson","year":"2015","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajur.2022.02.005","article-title":"Advances in penile-sparing surgical approaches","volume":"9","author":"Pang","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0240","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bju.15688","article-title":"Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000\u20132019","volume":"129","author":"Kristiansen","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0245","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","article-title":"Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents","volume":"62","author":"Alnajjar","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12466","article-title":"Imiquimod in the treatment of penile intraepithelial neoplasia: An update","volume":"58","author":"Deen","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.eururo.2023.02.027_b0255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.euf.2021.04.026","article-title":"Treatment options and outcomes for men with penile intraepithelial neoplasia: a systematic review","volume":"8","author":"Issa","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.02.027_b0260","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2017.01.024","article-title":"Need for evidence and consensus on laser treatment for management of select primary penile tumors","volume":"72","author":"Leone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0265","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bju.15297","article-title":"Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?","volume":"127","author":"Roussel","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0270","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bju.14222","article-title":"A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer","volume":"122","author":"Sri","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jclinpath-2013-201911","article-title":"Does the width of the surgical margin of safety or premalignant dermatoses at the negative surgical margin affect outcome in surgically treated penile cancer?","volume":"67","author":"Gunia","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.eururo.2023.02.027_b0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/2051415820903192","article-title":"Frozen section analysis for organ-conserving surgery in penile cancer: assessing oncological outcomes and trends of local recurrence","volume":"13","author":"Ellul","year":"2020","journal-title":"J Clin Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0285","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.juro.2017.01.088","article-title":"Organ sparing surgery for penile cancer: a systematic review","volume":"198","author":"Kamel","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urolonc.2017.09.028","article-title":"Laser ablation as monotherapy for penile squamous cell carcinoma: a multi-center cohort analysis","volume":"36","author":"Tang","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0295","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.euf.2018.02.002","article-title":"Surgical and oncological outcomes in patients after vascularised flap reconstruction for locoregionally advanced penile cancer","volume":"5","author":"Ottenhof","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.02.027_b0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/aja202188","article-title":"Neoadjuvant chemotherapy for patients with locally advanced penile cancer: an updated evidence","volume":"24","author":"Yi","year":"2022","journal-title":"Asian J Androl"},{"key":"10.1016\/j.eururo.2023.02.027_b0305","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urology.2013.05.021","article-title":"Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome","volume":"82","author":"Yao","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/bju.13009","article-title":"Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort","volume":"116","author":"Gopman","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ucl.2010.04.005","article-title":"Controversies in ilioinguinal lymphadenectomy","volume":"37","author":"Hegarty","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2023.02.027_b0320","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.juro.2013.06.016","article-title":"Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes","volume":"190","author":"Koifman","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2013.02.037","article-title":"Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis","volume":"64","author":"Stuiver","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0330","first-page":"204","article-title":"The risks of lymph node metastasis and the prognostic factors in carcinoma of the penis: analysis of 50 patients treated with bilateral ilioinguinal lymphadenectomy","volume":"84","author":"Leewansangtong","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.eururo.2023.02.027_b0335","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0019-509X.51359","article-title":"Impact of delay in inguinal lymph node dissection in patients with carcinoma of penis","volume":"46","author":"Gulia","year":"2009","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0340","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00345-014-1471-6","article-title":"Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection","volume":"33","author":"Sharma","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0345","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0022-5347(05)65169-5","article-title":"Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center experience","volume":"167","author":"Bevan-Thomas","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0350","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.eururo.2003.12.003","article-title":"Morbidity of inguinal lymphadenectomy for invasive penile carcinoma","volume":"45","author":"Bouchot","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0355","doi-asserted-by":"crossref","first-page":"578.e11","DOI":"10.1016\/j.urolonc.2019.05.024","article-title":"Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: effect on survival and complication rates","volume":"37","author":"Mistretta","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0360","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.ju.0000131453.52463.8f","article-title":"Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0365","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1007\/s00268-018-4604-z","article-title":"Minimizing post-operative complications of groin dissection using modified skin bridge technique: a single-centre descriptive study showing post-operative and early oncological outcomes","volume":"42","author":"Ray","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.eururo.2023.02.027_b0370","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/end.2012.0489","article-title":"Endoscopic inguinofemoral lymphadenectomy\u2014extended follow-up","volume":"27","author":"Schwentner","year":"2013","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2023.02.027_b0375","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.juro.2017.12.061","article-title":"Comparing outcomes of robotic and open inguinal lymph node dissection in patients with carcinoma of the penis","volume":"199","author":"Singh","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0380","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.euros.2021.10.004","article-title":"Saphenous-sparing ascending video endoscopic inguinal lymph node dissection using a leg approach: surgical technique and perioperative and pathological outcomes","volume":"35","author":"Fankhauser","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2023.02.027_b0385","first-page":"4623","article-title":"Comparison of efficiency of video endoscopy and open inguinal lymph node dissection","volume":"37","author":"Wang","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2023.02.027_b0390","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/s41598-022-06494-z","article-title":"Comparison of different surgical methods and strategies for inguinal lymph node dissection in patients with penile cancer","volume":"12","author":"Shao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2023.02.027_b0395","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.juro.2017.06.076","article-title":"Delay to inguinal lymph node dissection greater than 3 months predicts poorer recurrence-free survival for patients with penile cancer","volume":"198","author":"Chipollini","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0400","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0405","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","article-title":"The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection","volume":"31","author":"Liu","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0410","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0415","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0420","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00432-016-2292-3","article-title":"Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study","volume":"143","author":"Li","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0425","doi-asserted-by":"crossref","first-page":"641.e9","DOI":"10.1016\/j.urolonc.2020.03.026","article-title":"Adjuvant radiation compares favorably to chemotherapy in patients with carcinoma penis and nodal positivity restricted to groin","volume":"38","author":"Jaipuria","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0430","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0435","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","article-title":"DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation","volume":"54","author":"Maibom","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0440","doi-asserted-by":"crossref","first-page":"200.e11","DOI":"10.1016\/j.urolonc.2022.02.014","article-title":"Effectiveness and safety of adjuvant chemotherapy compared to neoadjuvant chemotherapy in patients with penile cancer and positive lymph nodes regarding overall survival and free disease survival: a systematic review and meta-analysis","volume":"40","author":"Paz Rojas","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0445","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.21037\/tau.2019.01.05","article-title":"Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure-a retrospective single centre study","volume":"8","author":"Alnajjar","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0450","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1590\/s1677-5538.ibju.2021.0169","article-title":"The role of primary inguinal surgical debulking for locally advanced penile cancer followed by reconstruction with myocutaneous flap","volume":"47","author":"Koifman","year":"2021","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0455","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/JU.0000000000000746","article-title":"Systematic review and meta-analysis\u2014is there a benefit in using neoadjuvant systemic chemotherapy for locally advanced penile squamous cell carcinoma?","volume":"203","author":"Azizi","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0460","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0465","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0470","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0475","doi-asserted-by":"crossref","first-page":"32212","DOI":"10.18632\/oncotarget.4802","article-title":"Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.02.027_b0480","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0485","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0490","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.eururo.2023.02.027_b0495","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0500","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","article-title":"Immune-based therapies in penile cancer","volume":"19","author":"Joshi","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0505","doi-asserted-by":"crossref","first-page":"S720","DOI":"10.1016\/j.annonc.2021.08.111","article-title":"715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: results of the penile cohort from the French AcS\u00e9 prospective program","volume":"32","author":"Pouessel","year":"2021","journal-title":"Ann Oncol"},{"issue":"6 Suppl","key":"10.1016\/j.eururo.2023.02.027_b0510","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JCO.2022.40.6_suppl.003","article-title":"Clinical results of PERICLES: a phase II trial investigating atezolizumab\u00a0\u00b1\u00a0radiotherapy for advanced squamous cell carcinoma of the penis","volume":"40","author":"de Vries","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0515","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urology.2013.08.074","article-title":"Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases","volume":"83","author":"Brown","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0520","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0525","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0530","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.02.027_b0535","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.2014.55.1143","article-title":"Role of radiation therapy in palliative care of the patient with cancer","volume":"32","author":"Lutz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0540","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0545","first-page":"e711","article-title":"MP49-15 Surveillance CT algorithm for node positive squamous cell carcinoma of the penis","volume":"201","author":"Ager","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0550","doi-asserted-by":"crossref","first-page":"S1033","DOI":"10.1016\/S0302-2838(22)00774-6","article-title":"A0694 - Patterns of recurrence in penile cancer: implications for surveillance strategies","volume":"81","author":"Arora","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0555","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/JU.0000000000001790","article-title":"Patterns of recurrence following inguinal lymph node dissection for penile cancer: optimizing surveillance strategies","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0560","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2020.03.058","article-title":"Oncological and functional outcomes after organ-sparing plastic reconstructive surgery for penile cancer","volume":"142","author":"P\u00e9rez","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0565","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brachy.2017.09.006","article-title":"Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma","volume":"17","author":"Gambachidze","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2023.02.027_b0570","doi-asserted-by":"crossref","first-page":"e1215","DOI":"10.1016\/j.clgc.2018.07.029","article-title":"Cross-sectional patient-reported outcome measuring of health-related quality of life with establishment of cancer- and treatment-specific functional and symptom scales in patients with penile cancer","volume":"16","author":"Draeger","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.02.027_b0575","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.juro.2014.04.014","article-title":"Quality of life for patients treated for penile cancer","volume":"192","author":"Kieffer","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejon.2017.08.011","article-title":"Assessment of quality of life in patients surgically treated for penile cancer: Impact of aggressiveness in surgery","volume":"31","author":"Sosnowski","year":"2017","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.eururo.2023.02.027_b0585","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ejso.2018.03.021","article-title":"A comparative study of two types of organ-sparing surgeries for early stage penile cancer: wide local excision vs partial penectomy","volume":"44","author":"Wan","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.eururo.2023.02.027_b0590","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.eururo.2007.10.028","article-title":"Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma","volume":"54","author":"Skeppner","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0595","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2021.02.011","article-title":"Phallus preservation in penile cancer surgery: patient-reported aesthetic & functional outcomes","volume":"152","author":"Croghan","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.02.027_b0600","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1464-410X.1994.tb09200.x","article-title":"Quality of life in patients treated for penile cancer","volume":"74","author":"Opjordsmoen","year":"1994","journal-title":"A follow-up study. Br J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0970-1591.114033","article-title":"Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma","volume":"29","author":"Gulino","year":"2013","journal-title":"Indian J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0610","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/21681805.2015.1077472","article-title":"DaPeCa-2: implementation of fast-track clinical pathways for penile cancer shortens waiting time and accelerates the diagnostic process\u2014a comparative before-and-after study in a tertiary referral centre in Denmark","volume":"50","author":"Jakobsen","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2023.02.027_b0615","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.euf.2021.09.019","article-title":"Centralization and equitable care in rare urogenital malignancies: the case for penile cancer","volume":"7","author":"Jakobsen","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.02.027_b0620","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1569-9056(14)60052-X","article-title":"Has centralisation of penile cancer services in the United Kingdom improved survival?","volume":"13","author":"Ayres","year":"2014","journal-title":"Eur Urol Suppl"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823026386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823026386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:13:51Z","timestamp":1759583631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823026386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0302283823026386"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}